Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

    • Option 1 [undo]
    • Provide tele-wound care education [undo]
    • Presentation [undo]
    • Ανεπιθύμητες ενέργειες φαρμακευτικής αγωγής [undo]
    • 10/10000 [undo]
    • White [undo]
    • Descrierea 3 [undo]
    • Node 9: Reassure her receive continuous supportw node [undo]
    • Grapefruit-simvastatin interaction [undo]
    • Inhibits the conversion of fibrinogen to fibrin [undo]
    • Buy non prescribed anti-anxiety medication [undo]
    • Ionuț va cere bani de la mama sa. [undo]
    • (1) προφάση, (2) μεσοφάση, (3) τελόφαση, (4) προμεταφάση, (5) μετάφαση και (6) ανάφαση [undo]
    • Node 10: Move to scheduling follow-up sessions [undo]
    • Live specimens [undo]
    • Node 14: Provide a support contact for technical issues [undo]
    • The result [undo]
    • Respond bluntly: “That is common in diabetes.” [undo]
    • The onset [undo]
    • Που θα οδηγήσει [undo]
    • Descrierea 2 [undo]
    • Commercial Platform [undo]
    • Ignore the emotional expression. [undo]
    • Temporarily stop taking metformin [undo]
    • Η εκπαιδευτικός μοιράζει τους ρόλους των ηθοποιών [undo]
    • Connecting Care Virtually: Building Trust and Teamwork in Digital Health Communication [undo]
    • Increased entry of fatty acids into adipocytes [undo]
    • Genotyping mice for the noveltin gene I: PCR Reagents [undo]
    • Decreased entry of glucose into muscle cells [undo]
    • 8 y.o. Child came in the ER with his mother [undo]
    • What should Anna do? [undo]
    • 27 [undo]
    • Verify patient identity and obtain e-consent before starting. [undo]
    • Option 2 [undo]
    • Gastrointestinal symptoms [undo]
    • Glipizide [undo]
    • Presentation [undo]
    • Larger area sample and when surface information is needed [undo]
    • Pioglitazone [undo]

    Map: Michael Green_GEMD_2 (1116)
    Node: 21115
    Score:

    reset

    OpenLabyrinth
    OpenLabyrinth is an open source educational pathway system

    Review your pathway